AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 35656683
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water (5 mL)
Trial: 36193978
Drug: High-dose dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dual therapy (HDDT) with esomeprazole 40 mg and amoxicillin 1000 mg three times daily for 14 days
Trial: 36193978
Drug: Bismuth-containing quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-containing quadruple therapy (TFEB) with esomeprazole 40 mg, bismuth potassium citrate 220 mg, furazolidone 100 mg twice daily, and tetracycline 500 mg three times daily for 14 days
Trial: 32713104
Drug: High-dose dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dual therapy (HDDT)
Trial: 36193978
Drug: Bismuth-containing quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-containing quadruple therapy (TFEB)
Trial: 35987013
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg twice daily)
Trial: 36278336
Drug: Sling exercise
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sling exercise therapy (SET) for 4 weeks
Trial: 33960674
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline irrigation twice daily using a 250-ml squeeze bottle in addition to standard treatment
Trial: 32787541
Drug: Active outreach
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active outreach strategies (e.g., tabling in busy areas, attending community events, utilising mixed media, collaborating with clinic staff)
Trial: 36105814
Drug: Half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half dose of ChAdOx1 nCoV-19 vaccine
Trial: 36105814
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose of ChAdOx1 nCoV-19 vaccine
Trial: 34534317
Drug: Estradiol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (100 µg/24 h) + Insulin (160 IU)
Trial: 34534317
Drug: Insulin (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (160 IU)
Trial: 32588034
Drug: High-speed power
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-speed power training (HSPT), 3 times weekly for 8 weeks
Trial: 35710215
Drug: Passive Vertebral
RxNorm normalized name: Sus scrofa cerebral cortex preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive Vertebral Mobilization (PVM) + Routine Physical Therapy (RPT)
Trial: 35710215
Drug: Routine Physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Physical Therapy (RPT)
Trial: 33078480
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day crocin for 12 weeks
Trial: 36067791
Drug: Honglilai Vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honglilai Vaginal Cream (0.625 mg/g) once daily for 3 weeks
Trial: 34383975
Drug: Morphine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine treatment
Trial: 36205036
Drug: Control (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (3 h of daily Uninterrupted Sitting)
Trial: 33650444
Drug: Social interaction
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Social interaction with a therapy dog (no physical interaction)
Trial: 33650444
Drug: Social plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social plus physical interaction with a therapy dog
Trial: 33650444
Drug: No interaction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No interaction with a therapy dog (control)
Trial: 32463593
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate ODT (50 mg) without water
Trial: 32755488
Drug: Optional prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optional prescription for oxycodone (group 2)
Trial: 34488843
Drug: Qualitative risk
RxNorm normalized name: Hep B, adolescent/high risk infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qualitative risk labels (e.g. 'very low risk')
Trial: 33788454
Drug: Moxibustion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion therapy (20 minutes each session, once every other day for 8 weeks)
Trial: 34491645
Drug: Acupuncture (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (at Neiguan (PC 6), Hegu (LI 4), Yintang (GV 29), and Baihui (GV 20), twice a day until mechanical ventilation was offline)
Trial: 34491645
Drug: Routine nursing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine nursing and treatment of severe pneumonia (Control group)
Trial: 37626303
Drug: Sugammadex (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (2 mg/kg)
Trial: 32910179
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human granulocyte colony-stimulating factor (rhG-CSF, 5 μg/kg, subcutaneously at days 0-2)
Trial: 32027446
Drug: Oxycodone once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone once-daily (OOD) with 240 mL of 0% alcohol
Trial: 32027446
Drug: Oxycodone once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone once-daily (OOD) with 240 mL of 40% alcohol
Trial: 32027446
Drug: Oxycodone twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxycodone twice-daily (OTD) with 240 mL of 40% alcohol
Trial: 32027446
Drug: Oxycodone twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxycodone twice-daily (OTD) with 240 mL of 0% alcohol
Trial: 34037715
Drug: Ustekinumab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab (both doses)
Trial: 36791986
Drug: Bupivacaine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (40 mL of 0.25% bupivacaine)
Trial: 36691187
Drug: Certain communication
RxNorm normalized name: cocklebur pollen extract
DrugBank: Xanthium strumarium pollen (DB10356)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Certain communication about COVID-19 vaccine effectiveness
Trial: 36691187
Drug: Uncertain communication
RxNorm normalized name: cocklebur pollen extract
DrugBank: Xanthium strumarium pollen (DB10356)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncertain communication about COVID-19 vaccine effectiveness
Trial: 32894088
Drug: fluoxetine-placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluoxetine-placebo
Trial: 32998416
Drug: Individualized Dietary
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized Dietary Prescription
Trial: 32879998
Drug: Cysteamine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cysteamine 5% cream
Trial: 34214153
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (10 or 30 μg daily)
Trial: 32434376
Drug: Auricular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular therapy (Group A)
Trial: 36169160
Drug: Clobetasol lotion
RxNorm normalized name: clobetasol Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol lotion 0.05% once at night
Trial: 33370050
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of ibuprofen (NSAID)
Trial: 33370050
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hydrocodone with 325 mg acetaminophen (opioid)
Trial: 33905350
Drug: Multidimensional family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidimensional family therapy (MDFT)
Trial: 32059704
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with Gemcitabine + Cisplatin (3 cycles pre- and post-surgery)
Trial: 32059704
Drug: Surgery alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery alone followed by therapy of investigator's choice
Trial: 35056349
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (electroacupuncture at left PC5, PC6, ST36, and ST37, once weekly for 12 weeks)
Trial: 35413570
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate (30 mg/day)
Trial: 36498457
Drug: Ramosetron (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron (5 μg; n = 35)
Trial: 32008289
Drug: Neostigmine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (2 mg) combined with atropine (0.5-1.0 mg)
Trial: 36167891
Drug: Daily multiple
RxNorm normalized name: Daily Multiple Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multiple micronutrient powder (MNP)
Trial: 36167891
Drug: Daily preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily preventive zinc tablets (PZ)
Trial: 34101714
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (0.5 μg kg‐1 h‐1) combined with GDHT
Trial: 32340838
Drug: Extracorporeal Shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Shock Wave Therapy and Dry Needling (ESWT-DN)
Trial: 34318597
Drug: Inhaled nezulcitinib
RxNorm normalized name: NEZULCITINIB
DrugBank: TD-0903 (DB16463)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nezulcitinib (10 mg)
Trial: 34318597
Drug: Inhaled nezulcitinib
RxNorm normalized name: NEZULCITINIB
DrugBank: TD-0903 (DB16463)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nezulcitinib (1, 3, or 10 mg)
Trial: 32546278
Drug: PGE2 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE2 treatment
Trial: 34422085
Drug: Extracorporeal Shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Shock Wave Therapy (ESWT), two times/week for 4 weeks
Trial: 33272279
Drug: mHealth solution
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth solution using the 24alife app with a compliance rate of 94.1%
Trial: 33272279
Drug: mHealth solution
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth solution using the 24alife app
Trial: 36431167
Drug: Topical intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical intervention (SuperCalm)
Trial: 36431167
Drug: Oral intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral intervention (InnerCalm)
Trial: 32024950
Drug: Daratumumab 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab 16 mg/kg intravenously on intense dosing schedule
Trial: 32024950
Drug: Daratumumab 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab 16 mg/kg intravenously on intermediate dosing schedule
Trial: 32024950
Drug: Daratumumab 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab 16 mg/kg intravenously on short dosing schedule
Trial: 33257632
Drug: FDC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC treatment in Shandong Province for six months
Trial: 33257632
Drug: FDC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC treatment in Jilin Province for six months
Trial: 36474739
Drug: Dorsal penile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorsal penile nerve block (DPNB) alone with 4 mg/kg plain lidocaine
Trial: 36474739
Drug: Lidocaine-prilocaine cream
RxNorm normalized name: lidocaine / prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine-prilocaine cream (LPC) applied to the phallus 1 hour before DPNB
Trial: 34016612
Drug: Cotadutide 100
RxNorm normalized name: Cotadutide
DrugBank: Cotadutide (DB15194)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotadutide 100 μg
Trial: 34016612
Drug: Cotadutide 200
RxNorm normalized name: Cotadutide
DrugBank: Cotadutide (DB15194)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotadutide 200 μg
Trial: 38729399
Drug: Cotadutide 300
RxNorm normalized name: Cotadutide
DrugBank: Cotadutide (DB15194)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotadutide 300 μg
Trial: 34740705
Drug: EDP-305 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDP-305 2.5 mg
Trial: 32827416
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no orthodontic treatment)
Trial: 33823377
Drug: Homeopathic dose
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic dose of pyridoxine (placebo, 59 of 105, 56%)
Trial: 32476164
Drug: Group intervention
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group intervention (n = 40); eight weekly 1.5-hour sessions
Trial: 32476164
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help (GSH) intervention (n = 31); self-study with eight weekly 20-minute phone calls
Trial: 33675398
Drug: Splint +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Splint + exercise therapy
Trial: 35533490
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no cold therapy)
Trial: 34620621
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ertugliflozin
Trial: 34620621
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg ertugliflozin
Trial: 33849723
Drug: Typbar-TCV® (WHO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typbar-TCV® (WHO prequalified vaccine)
Trial: 33849723
Drug: Typhim Vi®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhim Vi® (Vi polysaccharide vaccine)
Trial: 33289785
Drug: ACT on
RxNorm normalized name: Liver extract only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT on Health program plus weekly phone coaching
Trial: 34982866
Drug: Prolonged exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged exposure (PE) therapy for PTSD
Trial: 33079570
Drug: Direct-acting oral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting oral anticoagulants (DOACs)
Trial: 33314313
Drug: Active vibration
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active vibration therapy (30 Hz and 0.3 g)
Trial: 34480773
Drug: Imaginal exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imaginal exposure therapy
Trial: 35057755
Drug: Tablet-assisted motivational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-assisted motivational counselling at the participant's home and two follow-up telephone sessions
Trial: 35057755
Drug: Tablet-assisted motivational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-assisted motivational counselling
Trial: 34222044
Drug: HA-L vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-L vaccine
Trial: 34222044
Drug: HA-I vaccine
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-I vaccine
Trial: 32282927
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) performed by trained general interventional radiologists
Trial: 32282927
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) with aspiration and stent retrievers introduced in 2012
Trial: 32282927
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) in 2018
Trial: 33247344
Drug: Amoxicillin for
RxNorm normalized name: Amoxicillin for Oral Suspension
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin for 3 months
Trial: 33046213
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of the dopaminergic antagonist amisulpride
Trial: 35657611
Drug: Disease Modifying
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Trial: 38552197
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m2
Trial: 32563863
Drug: DHA-enriched fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-enriched fish oil (FO) 2 g/day (860 mg DHA + 120 mg EPA)
Trial: 35440345
Drug: Mass Prolonged
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass Prolonged Exposure (MPE) therapy
Trial: 35440345
Drug: Standard Prolonged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Prolonged Exposure (SPE) therapy
Trial: 33904589
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to attachment‐based family therapy (ABFT)
Trial: 33904589
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST)
Trial: 33904589
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to attachment‐based family therapy (ABFT) with therapeutic alliance as a moderator
Trial: 33904589
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST) with therapeutic alliance as a moderator
Trial: 34429646
Drug: Lidocaine topical
RxNorm normalized name: lidocaine topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine topical system 1.8% under swimming conditions
Trial: 34429646
Drug: Lidocaine topical
RxNorm normalized name: lidocaine topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine topical system 1.8% under showering conditions
Trial: 32606902
Drug: Lidocaine topical
RxNorm normalized name: lidocaine topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine topical system 1.8% under normal conditions
Trial: 33654425
Drug: Lidocaine topical
RxNorm normalized name: lidocaine topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine topical system 1.8%
Trial: 32293533
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) control group (n = 40)
Trial: 37676282
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitors (PPI)
Trial: 38249330
Drug: Cetuximab monotherapy
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab monotherapy
Trial: 32909356
Drug: Fecal microbiota
RxNorm normalized name: Fecal Microbiota
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fecal microbiota transplantation (FMT) by washed preparation
Trial: 32931950
Drug: Basophil activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basophil activation test (BAT) using shrimp extract as stimulant
Trial: 33438008
Drug: Ozanimod HCl
RxNorm normalized name: ozanimod HCl
DrugBank: Ozanimod (DB12612)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ozanimod HCl 1 mg daily
Trial: 35195913
Drug: Intravenous liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous liposomal irinotecan at 70 mg/m2
Trial: 32759848
Drug: EAT: Eating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EAT: Eating As Treatment intervention
Trial: 34543246
Drug: Propofol-based total
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol-based total intravenous anesthesia (TIVA group)
Trial: 35075551
Drug: Periarticular infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periarticular infiltration of low-dose dexamethasone
Trial: 35075551
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous dexamethasone
Trial: 35021269
Drug: DS-1211 (3-3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DS-1211 (3-3000 mg single dose)